Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial
Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a system update. No core study content, locations, or outcomes appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no observable changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary added; capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new Revision: v3.4.0 tag.SummaryDifference0.1%

- Check34 days agoChange DetectedLabel changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This clarifies that the update timestamp is precise rather than estimated.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed; these are minor site revision notes with no impact on study content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Locations section is updated to include Georgia, Maryland, Quebec, MI, RM, Gyeonggi-do, Seocho Gu, Andalusia, and Catalonia, and the previous location blocks are removed or reorganized accordingly.SummaryDifference0.7%

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.